Vironova AB (publ) granted US patent for a Thionation reagent.

STOCKHOLM, SWEDEN – Vironova AB, a leading Nano-Characterization technology and software company announced the approval of a new patent application. The US Patent Office (USPTO) has granted Vironova a patent for a Thionation reagent (no 13/936423). This patent is expected to be valid until 2032. Corresponding patents have been applied for all major markets. Based … Read more